Literature DB >> 21163317

High plasma nesfatin-1 level in patients with major depressive disorder.

Mustafa Ari1, Oktay Hasan Ozturk, Yasin Bez, Suleyman Oktar, Dudu Erduran.   

Abstract

AIM: In the present study, our aim was to determine the changes in the plasma concentrations of a recently discovered peptide hormone nesfatin-1 in patients with major depressive disorder and then to make a comparison with the control group.
METHOD: Subjects in the patient group were randomly selected from Mustafa Kemal University, Medical School, Research and Training Hospital, Psychiatry Department, Outpatient Clinic and subjects in the control group were selected from healthy volunteers. Healthy control subjects were matched in terms of weight and body mass index. Hamilton Depression Rating Scale (HAM-D) was applied to both groups. ELISA method was used for measurement of plasma nesfatin-1 levels.
RESULTS: The average nesfatin-1 level was statistically higher in patients with major depressive disorder than in the control group (p<0.001). A positive correlation was observed between plasma nesfatin-1 levels and HAM-D scores both in the patient group (r=0.59, p<0.001) and in the control group (r=0.58, p<0.001).
CONCLUSION: Our findings suggest a possible relationship between major depressive disorder and high plasma nesfatin-1 level.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163317     DOI: 10.1016/j.pnpbp.2010.12.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  26 in total

1.  Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.

Authors:  Rulin Deniz; Bilgin Gurates; Suleyman Aydin; Husnu Celik; Ibrahim Sahin; Yakup Baykus; Zekiye Catak; Aziz Aksoy; Cihan Citil; Sami Gungor
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

Review 2.  Nesfatin-1 and its effects on different systems.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

3.  CRHR1 Mediates the Up-Regulation of Synapsin I Induced by Nesfatin-1 Through ERK 1/2 Signaling in SH-SY5Y Cells.

Authors:  Zheng Chen; Ya-Yun Xu; Jin-Fang Ge; Fei-Hu Chen
Journal:  Cell Mol Neurobiol       Date:  2017-06-12       Impact factor: 5.046

Review 4.  "Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin.

Authors:  Xi Chen; Jing Dong; Qian Jiao; Xixun Du; Mingxia Bi; Hong Jiang
Journal:  Cell Mol Life Sci       Date:  2022-03-03       Impact factor: 9.261

Review 5.  Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders.

Authors:  Milind V Masule; Sumit Rathod; Yogeeta Agrawal; Chandragouda R Patil; Kartik T Nakhate; Shreesh Ojha; Sameer N Goyal; Umesh B Mahajan
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-06-13

Review 6.  Multi-functional peptide hormone NUCB2/nesfatin-1.

Authors:  Suleyman Aydin
Journal:  Endocrine       Date:  2013-03-23       Impact factor: 3.633

Review 7.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

8.  The Relationship between Nesfatin-1 Levels and SYNTAX Score in Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Mevlüt Serdar Kuyumcu; Aliye Kuyumcu; Çağrı Yayla; Mustafa Bilal Özbay; Sefa Ünal; Burak Açar; Cemil Nural; Almila Şenat; Gülhan Samur
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

9.  Nesfatin-1/NUCB2 as a potential new element of sleep regulation in rats.

Authors:  Szilvia Vas; Csaba Ádori; Katalin Könczöl; Zita Kátai; Dorottya Pap; Rege S Papp; György Bagdy; Miklós Palkovits; Zsuzsanna E Tóth
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

10.  Is there any association between low level of serum nesfatin-1 and fibromyalgia syndrome?

Authors:  Birşen Bilgici; Yeşim Akyol; Yasemin Ulus; Sebati Sinan Ürkmez; Ömer Kuru
Journal:  Arch Rheumatol       Date:  2020-07-01       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.